The first presentation at the Boehringer Ingelheim Foundations Seminar was on the “Impact of a modified-live PRRS vaccine intervention on a population of pigs infected with a heterologous isolates.” Presenting was Dr. J. P. Cano from Venezuala.
His presentation was on the results of 2 different studies that showed an increase in clinical response to a virus challenge. He says, however, that besides vaccination producers need to consider other options for PRRS control at the same time since there isn’t any silver bullet solution.
You can listen to my interview with Dr. Cano here: bi-foundations-08-cano.mp3